Keiji Nogami

57PUBLICATIONS
63CO-AUTHORS
Preventative health careHaematologyExercise physiologyInfant and child healthForensic epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Aug 08, 2025
Development of Awareness Materials to Promote Early Diagnosis of Undiagnosed von Willebrand Disease: Integration of Multidisciplinary Perspectives Based on a Literature Review.

Azusa Nagao, Masahiro Takeyama, Kenichi Ogiwara

|Jul 08, 2025
Coagulation Potential in Haemostatic Agents Concomitant With Low Concentration of Emicizumab Under Severe Haemophilia A State.

Yuki Kawasaki, Yuto Nakajima, Keiji Nogami

|Jun 19, 2025
TSUBASA Study: Evaluating Association of Physical Activity and Bleeding Events in People With Haemophilia A Without Factor VIII Inhibitors Receiving Emicizumab.

Kagehiro Amano, Teruhisa Fujii, Akihiro Sawada

|May 05, 2025
Real-World Unmet Needs of Patients With Haemophilia A and Haemophilia B With or Without Inhibitors: End-of-Study Results From the explorer6 Non-Interventional Study.

Allison P Wheeler, Aby Abraham, Chris Barnes

|Jan 06, 2025
Hemostatic Dynamics Mainly Based on Hypofibrinolysis During Early-Phase Interfant-Type Chemotherapy in Three Infants with Acute Lymphoblastic Leukemia: Results from Japan Children's Cancer Group ThrombALL-MLL-17.

Takashi Ishihara, Tomoko Onishi, Shinya Osone

|Dec 26, 2024
HINODE study: haemophilia A in infancy and newborns - protocol for a prospective, multicentre, observational study evaluating the coagulation potential and safety of emicizumab prophylaxis.

Shouichi Ohga, Masahiro Takeyama, Masataka Ishimura

Pageof 10

Frequent Collaborators

12 joint publications

Midori Shima

8 joint publications

Yuto Nakajima

7 joint publications

Shoko Furukawa

6 joint publications

Masahiro Takeyama